Jonathan Mermin

Author PubWeight™ 195.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011 13.03
2 Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006 9.45
3 Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 2002 5.80
4 Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med 2013 5.39
5 Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006 5.34
6 Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007 4.52
7 The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS 2009 4.45
8 Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009 4.33
9 Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol 2004 3.92
10 Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006 3.80
11 Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 2007 3.69
12 Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One 2009 3.66
13 HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS 2008 3.52
14 Unfinished business--expanding HIV testing in developing countries. N Engl J Med 2006 3.48
15 Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr 2006 3.38
16 Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006 3.18
17 Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr 2010 2.83
18 Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav 2007 2.78
19 Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr 2006 2.67
20 Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS Behav 2006 2.59
21 Home-based model for HIV voluntary counselling and testing. Lancet 2003 2.57
22 HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA 2006 2.51
23 Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008 2.49
24 CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2008 2.32
25 Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr 2012 2.15
26 Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg 2005 2.12
27 Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One 2010 2.12
28 Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study. PLoS One 2012 2.10
29 Estimating per-act HIV transmission risk: a systematic review. AIDS 2014 2.04
30 Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav 2006 2.01
31 Ebola virus disease in health care workers--Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep 2014 1.99
32 Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr 2013 1.98
33 Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr 2007 1.97
34 CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ 2011 1.96
35 The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy 2009 1.94
36 Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One 2011 1.68
37 Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bull World Health Organ 2011 1.61
38 Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States. AIDS 2014 1.61
39 Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr 2005 1.59
40 Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr 2010 1.58
41 Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One 2011 1.56
42 Home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda. J Acquir Immune Defic Syndr 2007 1.52
43 Use of a nationwide call center for Ebola response and monitoring during a 3-day house-to-house campaign - Sierra Leone, September 2014. MMWR Morb Mortal Wkly Rep 2015 1.52
44 Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr 2008 1.51
45 A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr 2010 1.48
46 HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis 2012 1.45
47 Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J Infect Dis 2012 1.42
48 Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep 2015 1.39
49 Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2010 1.38
50 Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006 1.35
51 The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS 2008 1.34
52 Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr 2014 1.33
53 HIV infection and older Americans: the public health perspective. Am J Public Health 2012 1.31
54 Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Res Ther 2007 1.30
55 Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014. MMWR Morb Mortal Wkly Rep 2014 1.30
56 Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr 2006 1.29
57 Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health 2012 1.27
58 Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS 2011 1.25
59 Trends in HIV prevalence and HIV testing among young MSM: five United States cities, 1994-2011. AIDS Behav 2014 1.22
60 Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2011 1.21
61 Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr 2007 1.20
62 Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 2006 1.20
63 Correlates of HIV Infection Among Sexually Active Adults in Kenya: A National Population-Based Survey. Open AIDS J 2011 1.19
64 Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One 2012 1.18
65 Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses 2011 1.16
66 Comparison of HIV prevalence estimates from sentinel surveillance and a national population-based survey in Uganda, 2004-2005. J Acquir Immune Defic Syndr 2009 1.14
67 Nevirapine-induced Stevens-Johnson syndrome in a mother and son. AIDS 2005 1.13
68 Unsafe sex among HIV-infected adults in Kenya: results of a nationally representative survey. J Acquir Immune Defic Syndr 2011 1.13
69 A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics 2012 1.11
70 Trends in HIV-related behaviors and knowledge in Uganda, 1989-2005: evidence of a shift toward more risk-taking behaviors. J Acquir Immune Defic Syndr 2008 1.10
71 Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav 2008 1.07
72 Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis 2011 1.05
73 Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J 2009 1.05
74 Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda. Ann Trop Paediatr 2006 1.03
75 Measuring quality of life in rural Uganda: reliability and validity of summary scores from the medical outcomes study HIV health survey (MOS-HIV). Qual Life Res 2011 1.00
76 Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006 0.98
77 Male circumcision programmes in Kenya: lessons from the Kenya AIDS Indicator Survey 2007. Bull World Health Organ 2012 0.98
78 Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS 2008 0.97
79 HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies. AIDS 2014 0.97
80 Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 2003 0.96
81 The need for partner consent is a main reason for opting out of routine HIV testing for prevention of mother-to-child transmission in a rural Ugandan hospital. J Acquir Immune Defic Syndr 2007 0.96
82 Prevention with people with HIV in the United States: the nexus of HIV prevention and treatment. J Acquir Immune Defic Syndr 2012 0.93
83 Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda. AIDS 2003 0.93
84 HIV testing: current practice and future directions. Curr HIV/AIDS Rep 2013 0.92
85 Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda. J Int Assoc Physicians AIDS Care (Chic) 2009 0.92
86 Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus. Am J Trop Med Hyg 2010 0.91
87 HIV, syphilis, herpes simplex virus 2, and behavioral surveillance among conflict-affected populations in Yei and Rumbek, southern Sudan. AIDS 2006 0.91
88 The effect of HIV on morbidity and mortality in children with severe malarial anaemia. Malar J 2007 0.90
89 Establishing the diagnosis of HIV infection: new tests and a new algorithm for the United States. J Clin Virol 2011 0.90
90 Monitoring antiretroviral failure in resource-poor settings. Lancet 2008 0.90
91 Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa? AIDS 2005 0.90
92 An outbreak of food-borne illness associated with methomyl-contaminated salt. JAMA 2002 0.88
93 Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013. MMWR Morb Mortal Wkly Rep 2015 0.87
94 Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States. AIDS 2017 0.87
95 Incorporating couples-based approaches into HIV prevention for gay and bisexual men: opportunities and challenges. Arch Sex Behav 2014 0.85
96 Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg 2006 0.85
97 Applying Public Health Principles to the HIV Epidemic--How Are We Doing? N Engl J Med 2015 0.84
98 Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya. AIDS 2013 0.83
99 The Importance of Population Denominators for High-Impact Public Health for Marginalized Populations. JMIR Public Health Surveill 2016 0.83
100 The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy. J Int AIDS Soc 2013 0.81
101 Quantitation of human herpesvirus 8 (HHV-8) antibody in patients transfused with HHV-8-seropositive blood. Transfusion 2009 0.78
102 Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons Tested. J Public Health Manag Pract 2016 0.78
103 Integrating tuberculosis and HIV services in Africa. Int J Tuberc Lung Dis 2008 0.75
104 Changing from anonymous to confidential HIV voluntary counseling and testing in Uganda. AIDS 2005 0.75
105 Using Surveillance Data to Assess the HIV Tipping Point in the United States. J Acquir Immune Defic Syndr 2015 0.75
106 An occasion for pause and reflection--challenges to public health during times of instability: a report from the Centers for Disease Control and Prevention and the Kenya Medical Research Institute on the post-election violence in Kenya. Am J Trop Med Hyg 2008 0.75
107 Using the National HIV Behavioral Surveillance System to inform HIV prevention efforts in the United States. AIDS Behav 2014 0.75